Literature DB >> 26711540

Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.

Megan E Patrick1, Patrick M O'Malley2, Deborah D Kloska2, John E Schulenberg2,3, Lloyd D Johnston2, Richard A Miech2, Jerald G Bachman2.   

Abstract

INTRODUCTION AND AIMS: The current study documents the characteristics associated with the use of two novel psychoactive substances: synthetic cannabinoids and synthetic cathinones. DESIGN AND METHODS: Nationally representative samples of students in 8th (n = 9665), 10th (n = 10 655) and 12th (n = 10 057) grades across the US were included in the Monitoring the Future study from 2012 to 2014.
RESULTS: There were relatively few differences in prevalence based on sociodemographic characteristics, although boys were at greater risk for use of synthetic cannabinoids in 12th grade (used by 10.3% of boys and 6.4% of girls) and for use of synthetic cathinones in 10th grade (used by 1.0% of boys and 0.4% of girls). Synthetic drug use was also associated with truancy and use of cigarettes, alcohol, and marijuana. DISCUSSION AND
CONCLUSIONS: Prevention and intervention efforts for novel psychoactive substance use should focus primarily on polysubstance users and youth who are disengaged from school.[Patrick M, O'Malley P, Kloska D, Schulenberg J, Johnston L, Miech R, Bachman J. Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones. Drug Alcohol Rev 2016;35:586-590].
© 2015 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  bath salts; novel psychoactive substances; synthetic cannabinoids; synthetic cathinones; synthetic marijuana

Mesh:

Substances:

Year:  2015        PMID: 26711540      PMCID: PMC4927404          DOI: 10.1111/dar.12372

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  11 in total

Review 1.  Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

Authors:  Kathryn A Seely; Jeff Lapoint; Jeffery H Moran; Liana Fattore
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-04-26       Impact factor: 5.067

2.  The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products.

Authors:  Adam R Winstock; Monica J Barratt
Journal:  Hum Psychopharmacol       Date:  2013-07       Impact factor: 1.672

3.  "Bath salt" use among a nationally representative sample of high school seniors in the United States.

Authors:  Joseph J Palamar
Journal:  Am J Addict       Date:  2015-07-14

4.  Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample.

Authors:  Adam Winstock; Michael Lynskey; Rohan Borschmann; Jon Waldron
Journal:  J Psychopharmacol       Date:  2015-03-10       Impact factor: 4.153

Review 5.  Current "legal highs".

Authors:  Lucas A Johnson; Rebecca L Johnson; Ray-Bernard Portier
Journal:  J Emerg Med       Date:  2013-03-23       Impact factor: 1.484

6.  Synthetic Cannabinoid Abuse in Adolescents: A Case Series.

Authors:  Gulser Esen Besli; Mehmet Alper Ikiz; Sema Yildirim; Selcuk Saltik
Journal:  J Emerg Med       Date:  2015-08-17       Impact factor: 1.484

7.  Awash in a sea of 'bath salts': implications for biomedical research and public health.

Authors:  Michael H Baumann
Journal:  Addiction       Date:  2014-07-01       Impact factor: 6.526

8.  Synthetic cannabinoid use in a nationally representative sample of US high school seniors.

Authors:  Joseph J Palamar; Patricia Acosta
Journal:  Drug Alcohol Depend       Date:  2015-02-11       Impact factor: 4.492

9.  Patterns of synthetic cannabinoid use in Australia.

Authors:  Monica J Barratt; Vince Cakic; Simon Lenton
Journal:  Drug Alcohol Rev       Date:  2012-10-09

Review 10.  Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports.

Authors:  Karen Miotto; Joan Striebel; Arthur K Cho; Christine Wang
Journal:  Drug Alcohol Depend       Date:  2013-08-01       Impact factor: 4.492

View more
  12 in total

1.  Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.

Authors:  Andrew A Monte; Diane P Calello; Roy R Gerona; Eike Hamad; Sharan L Campleman; Jeffery Brent; Paul Wax; Robert G Carlson
Journal:  J Med Toxicol       Date:  2017-04-10

2.  Sex differences in inflammatory cytokine levels following synthetic cathinone self-administration in rats.

Authors:  Julie A Marusich; Elaine A Gay; Delisha A Stewart; Bruce E Blough
Journal:  Neurotoxicology       Date:  2021-11-04       Impact factor: 4.294

3.  Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.

Authors:  Katherine M Keyes; Caroline Rutherford; Ava Hamilton; Joseph J Palamar
Journal:  Drug Alcohol Depend       Date:  2016-07-28       Impact factor: 4.492

4.  Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion.

Authors:  Demilade A Adedinsewo; Oluwaseun Odewole; Taylor Todd
Journal:  N Am J Med Sci       Date:  2016-06

5.  Cluster randomised controlled trial of an online intervention to prevent ecstasy and new psychoactive substance use among adolescents: final results and implications for implementation.

Authors:  Katrina E Champion; Nicola Clare Newton; Lexine Stapinski; Maree Teesson
Journal:  BMJ Open       Date:  2018-11-25       Impact factor: 2.692

6.  Repeated Use of the Psychoactive Substance Ethylphenidate Impacts Neurochemistry and Reward Learning in Adolescent Male and Female Mice.

Authors:  Meridith T Robins; Arryn T Blaine; Jiwon E Ha; Amy L Brewster; Richard M van Rijn
Journal:  Front Neurosci       Date:  2019-02-19       Impact factor: 4.677

7.  Alcohol Binge-Induced Cardiovascular Dysfunction Involves Endocannabinoid-CB1-R Signaling.

Authors:  Janos Paloczi; Csaba Matyas; Resat Cinar; Zoltan V Varga; György Hasko; Thomas H Schindler; George Kunos; Pal Pacher
Journal:  JACC Basic Transl Sci       Date:  2019-09-23

8.  Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats.

Authors:  Devan M Gomez; Thomas J Everett; Lindsey R Hamilton; Ajit Ranganath; Joseph F Cheer; Erik B Oleson
Journal:  Neuropharmacology       Date:  2020-10-25       Impact factor: 5.250

Review 9.  Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.

Authors:  Krista M Lisdahl; Kenneth J Sher; Kevin P Conway; Raul Gonzalez; Sarah W Feldstein Ewing; Sara Jo Nixon; Susan Tapert; Hauke Bartsch; Rita Z Goldstein; Mary Heitzeg
Journal:  Dev Cogn Neurosci       Date:  2018-02-21       Impact factor: 5.811

10.  Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.

Authors:  Jessica Neicun; Justin Christopher Yang; Hueyjong Shih; Pranay Nadella; Robin van Kessel; Attilio Negri; Kasia Czabanowska; Carol Brayne; Andres Roman-Urrestarazu
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.